Skip to main content
. 2011 Apr 28;3(2):2223–2242. doi: 10.3390/cancers3022223

Figure 5.

Figure 5.

Kaplan-Meier analysis comparing the number of disease-free days of all patients with those that did or did not develop anti-KLH antibodies.